EA201791696A1 - Композиция для лечения веноокклюзионной болезни печени - Google Patents
Композиция для лечения веноокклюзионной болезни печениInfo
- Publication number
- EA201791696A1 EA201791696A1 EA201791696A EA201791696A EA201791696A1 EA 201791696 A1 EA201791696 A1 EA 201791696A1 EA 201791696 A EA201791696 A EA 201791696A EA 201791696 A EA201791696 A EA 201791696A EA 201791696 A1 EA201791696 A1 EA 201791696A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- veno
- composition
- disease
- acclusion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5578—Eicosanoids, e.g. leukotrienes or prostaglandins having a pentalene ring system, e.g. carbacyclin, iloprost
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
- A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Настоящее изобретение обеспечивает композицию, включающую аналог простациклина, его производное или его фармацевтически пригодную соль, для применения в профилактике или лечении синдрома синусоидальной обструкции и/или веноокклюзионной болезни печени, а также режимы их лечения.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15152665 | 2015-01-27 | ||
PCT/EP2016/051675 WO2016120311A1 (en) | 2015-01-27 | 2016-01-27 | Composition for the treatment of hepatic veno-occlusive disease |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201791696A1 true EA201791696A1 (ru) | 2017-11-30 |
Family
ID=52394992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201791696A EA201791696A1 (ru) | 2015-01-27 | 2016-01-27 | Композиция для лечения веноокклюзионной болезни печени |
Country Status (14)
Country | Link |
---|---|
US (1) | US20180021347A1 (ru) |
EP (1) | EP3250289A1 (ru) |
JP (1) | JP2018503654A (ru) |
KR (1) | KR20170106360A (ru) |
CN (1) | CN107592811A (ru) |
AU (1) | AU2016212091A1 (ru) |
BR (1) | BR112017016084A2 (ru) |
CA (1) | CA2973147A1 (ru) |
CL (1) | CL2017001904A1 (ru) |
EA (1) | EA201791696A1 (ru) |
IL (1) | IL253390A0 (ru) |
SG (1) | SG11201705809QA (ru) |
WO (1) | WO2016120311A1 (ru) |
ZA (1) | ZA201704957B (ru) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102647979B (zh) | 2009-06-12 | 2015-03-04 | 曼金德公司 | 具有确定比表面积的二酮哌嗪颗粒 |
US9505737B2 (en) | 2013-01-11 | 2016-11-29 | Corsair Pharma, Inc. | Treprostinil derivative compounds and methods of using same |
JP6542128B2 (ja) | 2013-01-11 | 2019-07-10 | コルセア ファーマ インコーポレイテッド | トレプロスチニルのプロドラッグ |
SG11201507564PA (en) | 2013-03-15 | 2015-10-29 | Mannkind Corp | Microcrystalline diketopiperazine compositions and methods |
MX2020009878A (es) | 2013-07-18 | 2022-07-27 | Mannkind Corp | Composiciones farmaceuticas en polvo seco estables al calor y metodos. |
US9643911B2 (en) | 2015-06-17 | 2017-05-09 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
US9394227B1 (en) | 2015-06-17 | 2016-07-19 | Corsair Pharma, Inc. | Treprostinil derivatives and compositions and uses thereof |
EP3498283A1 (en) | 2017-12-14 | 2019-06-19 | Ipsol AG | Glycosidic derivatives of treprostinil |
AU2020211412A1 (en) * | 2019-01-25 | 2021-08-12 | Janssen Pharmaceutica Nv | Methods for mitigating liver injury and promoting liver hypertrophy, regeneration and cell engraftment in conjunction with radiation and/or radiomimetic treatments |
-
2016
- 2016-01-27 CN CN201680010849.4A patent/CN107592811A/zh active Pending
- 2016-01-27 KR KR1020177021201A patent/KR20170106360A/ko unknown
- 2016-01-27 SG SG11201705809QA patent/SG11201705809QA/en unknown
- 2016-01-27 BR BR112017016084A patent/BR112017016084A2/pt not_active Application Discontinuation
- 2016-01-27 EA EA201791696A patent/EA201791696A1/ru unknown
- 2016-01-27 WO PCT/EP2016/051675 patent/WO2016120311A1/en active Application Filing
- 2016-01-27 CA CA2973147A patent/CA2973147A1/en not_active Abandoned
- 2016-01-27 JP JP2017539662A patent/JP2018503654A/ja active Pending
- 2016-01-27 EP EP16701551.0A patent/EP3250289A1/en not_active Withdrawn
- 2016-01-27 AU AU2016212091A patent/AU2016212091A1/en not_active Abandoned
- 2016-01-27 US US15/547,060 patent/US20180021347A1/en not_active Abandoned
-
2017
- 2017-07-10 IL IL253390A patent/IL253390A0/en unknown
- 2017-07-20 ZA ZA2017/04957A patent/ZA201704957B/en unknown
- 2017-07-25 CL CL2017001904A patent/CL2017001904A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP3250289A1 (en) | 2017-12-06 |
WO2016120311A1 (en) | 2016-08-04 |
SG11201705809QA (en) | 2017-08-30 |
CN107592811A (zh) | 2018-01-16 |
ZA201704957B (en) | 2018-12-19 |
KR20170106360A (ko) | 2017-09-20 |
JP2018503654A (ja) | 2018-02-08 |
AU2016212091A1 (en) | 2017-08-03 |
CL2017001904A1 (es) | 2018-03-23 |
US20180021347A1 (en) | 2018-01-25 |
BR112017016084A2 (pt) | 2018-03-27 |
IL253390A0 (en) | 2017-09-28 |
CA2973147A1 (en) | 2016-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201791696A1 (ru) | Композиция для лечения веноокклюзионной болезни печени | |
CY1123595T1 (el) | Παραγωγα χολικου οξεος ως αγωνιστες fxr/tgr5 | |
DOP2016000298A (es) | Pirazolopiridinas y pirazolopirimidinas | |
EA201791420A1 (ru) | Соединения триазолопиримидина и их применения | |
EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
TR201901886T4 (tr) | DNA-PK inhibitörleri. | |
UY36056A (es) | “compuestos de heteroarilo o arilo bicíclicos fusionados “. | |
CL2016002072A1 (es) | 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer | |
EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
EA201691421A1 (ru) | Гетероарилы и их применение | |
EA201500383A1 (ru) | Производные 1,2,4-триазина для лечения вирусных инфекций | |
CL2018000565A1 (es) | Compuestos derivados de piridinona dicarboxamida, inhibidores de bromodominio; composicion farmaceutica; combinacion farmaceutica; utiles en el tratamiento de enfermedades autoinmunitarias, inflamatorias, virales y cancer, entre otras. | |
EA202090098A1 (ru) | Фармацевтические композиции терапевтически активных соединений | |
EA201591406A1 (ru) | C-19 модифицированные тритерпеноиды с ингибиторной активностью созревания вич | |
CL2015002897A1 (es) | Inhibidores de bace1 | |
EA201692470A1 (ru) | Фармацевтические комбинации | |
EA201791807A1 (ru) | Новый тритерпенон по с-3 с обратными амидными производными по с-17 в качестве ингибиторов вич | |
EA201792057A1 (ru) | Конденсированные бициклические гетероарильные производные с активностью ингибиторов пролилгидроксилазы | |
EA201691412A1 (ru) | Гидроксиформамидные производные и их применение | |
CL2016002839A1 (es) | Derivados de carboxamida | |
EA201690783A1 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний | |
DOP2016000297A (es) | Composiciones farmacéuticas útiles para tratar enfermedades infecciosas | |
EA201691566A1 (ru) | Применение производных пиридазина для предупреждения или лечения атаксического синдрома | |
EA201990095A1 (ru) | КОНДЕНСИРОВАННЫЕ ТИОФЕНОВЫЕ ПРОИЗВОДНЫЕ, ПРИЕМЛЕМЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ NAPI-IIb | |
EA201792264A1 (ru) | Способы лечения воспалительных заболеваний |